AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2014-06-25
$27.12
+0.09 (+0.33%)
last quote
Want the full multi-source brief on AMPH?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$27.12
High
$27.39
Low
$26.84
Previous close
$27.03
Fundamentals
Market cap
$1.15B
P/E (TTM)
14.64x
P/S (TTM)
1.57x
P/B
1.56x
Gross margin
47.68%
Operating margin
15.66%
Net margin
10.76%
Rev growth (YoY)
1.02%
EPS growth (YoY)
-35.99%
ROE
10.11%
52W high
$29.52
52W low
$16.65
Beta
0.90x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-05todayafter market
Q3 2026EPS est $0.88Rev est $201.8M
Recent SEC filings
CIK 1297184filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 4d
3 profitable stocks with warning signs
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Yahoo · 5d
BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates
BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of +30.00% and +19.08%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · 6d
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · 6d
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its third quarter of 2026 ended September 30, 2026, after the market closes on Thursday, November 5, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.
Yahoo · 6d
3 value stocks that fall short
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Yahoo · 6d
Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates
Bausch (BHC) delivered earnings and revenue surprises of +63.89% and +7.11%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial